Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harun Fajkovic

Showing results (71-80 of 138) with videos related to

Pageof 14
Sort By:
Urologic Oncology|March 27, 2020
The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC)Florian Janisch, David D'Andrea, Takehiro Iwata, et al.
World Journal of Urology|November 18, 2023
Comparison of EEP and TURP long-term outcomes: systematic review and meta-analysisAndrey Morozov, Mark Taratkin, Anastasia Shpikina, et al.
Urologic Oncology|October 22, 2013
Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinomaMalte Rieken, Evanguelos Xylinas, Luis Kluth, et al.
The Journal of Urology|December 17, 2013
Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancerTobias Klatte, Evanguelos Xylinas, Malte Rieken, et al.
The Prostate|October 16, 2019
Response assessment using [<sup>68</sup> Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancerBernhard Grubmüller, Sazan Rasul, Pascal Baltzer, et al.
BJU International|September 24, 2013
Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancerMalte Rieken, Evanguelos Xylinas, Luis Kluth, et al.
World Journal of Urology|February 17, 2016
Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinomaHarun Fajkovic, Shahrokh F Shariat, Tobias Klatte, et al.
European Urology Focus|November 25, 2022
Oncologic and Safety Outcomes for Retrograde and Antegrade Endoscopic Surgeries for Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysisEkaterina Laukhtina, Tatsushi Kawada, Fahad Quhal, et al.
World Journal of Urology|October 19, 2023
Thulium fiber laser vs Ho:YAG in RIRS: a prospective randomized clinical trial assessing the efficacy of lasers and different fiber diameters (150 µm and 200 µm)Mark Taratkin, Camilla Azilgareeva, Vladislav Petov, et al.
European Urology Focus|December 3, 2022
Oncologic and Safety Outcomes for Endoscopic Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An Updated Systematic Review and Meta-analysisTatsushi Kawada, Ekaterina Laukhtina, Fahad Quhal, et al.
Pageof 14

Showing results (71-80 of 138) with videos related to

Sort By:
Pageof 14
Urologic Oncology|March 27, 2020
The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC)Florian Janisch, David D'Andrea, Takehiro Iwata, et al.
World Journal of Urology|November 18, 2023
Comparison of EEP and TURP long-term outcomes: systematic review and meta-analysisAndrey Morozov, Mark Taratkin, Anastasia Shpikina, et al.
Urologic Oncology|October 22, 2013
Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinomaMalte Rieken, Evanguelos Xylinas, Luis Kluth, et al.
The Journal of Urology|December 17, 2013
Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancerTobias Klatte, Evanguelos Xylinas, Malte Rieken, et al.
The Prostate|October 16, 2019
Response assessment using [<sup>68</sup> Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancerBernhard Grubmüller, Sazan Rasul, Pascal Baltzer, et al.
BJU International|September 24, 2013
Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancerMalte Rieken, Evanguelos Xylinas, Luis Kluth, et al.
World Journal of Urology|February 17, 2016
Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinomaHarun Fajkovic, Shahrokh F Shariat, Tobias Klatte, et al.
European Urology Focus|November 25, 2022
Oncologic and Safety Outcomes for Retrograde and Antegrade Endoscopic Surgeries for Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysisEkaterina Laukhtina, Tatsushi Kawada, Fahad Quhal, et al.
World Journal of Urology|October 19, 2023
Thulium fiber laser vs Ho:YAG in RIRS: a prospective randomized clinical trial assessing the efficacy of lasers and different fiber diameters (150 µm and 200 µm)Mark Taratkin, Camilla Azilgareeva, Vladislav Petov, et al.
European Urology Focus|December 3, 2022
Oncologic and Safety Outcomes for Endoscopic Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An Updated Systematic Review and Meta-analysisTatsushi Kawada, Ekaterina Laukhtina, Fahad Quhal, et al.
Pageof 14